Postmortem Alteration of Purine Metabolism in Coronary Artery Disease
Open Access
- 8 November 2023
- journal article
- research article
- Published by MDPI AG in Metabolites
- Vol. 13 (11) , 1135
Abstract
A new approach for assisting in the diagnosis of coronary artery disease (CAD) as a cause of death is essential in cases where complete autopsy examinations are not feasible. The purine pathway has been associated with CAD patients, but the understanding of this pathway in postmortem changes needs to be explored. This study investigated the levels of blood purine metabolites in CAD after death. Heart blood samples (n = 60) were collected and divided into CAD (n = 23) and control groups (n = 37). Purine metabolites were measured via proton nuclear magnetic resonance. Guanosine triphosphate (GTP), nicotinamide adenine dinucleotide (NAD), and xanthine levels significantly decreased (p < 0.05); conversely, adenine and deoxyribose 5-phosphate levels significantly increased (p < 0.05) in the CAD group compared to the control group. Decreasing xanthine levels may serve as a marker for predicting the cause of death in CAD (AUC = 0.7). Our findings suggest that the purine pathway was interrupted by physiological processes after death, causing the metabolism of the deceased to differ from that of the living. Additionally, xanthine levels should be studied further to better understand their relationship with CAD and used as a biomarker for CAD diagnosis under decomposition and skeletonization settings.Keywords
Funding Information
- Chiang Mai University (FRB640006)
This publication has 46 references indexed in Scilit:
- Biochemistry Changes That Occur after Death: Potential Markers for Determining Post-Mortem IntervalPLOS ONE, 2013
- Guidelines for forensic assessment of natural unexpected cardiovascular deathBasic and Applied Pathology, 2008
- Metabolite profiling of blood from individuals undergoing planned myocardial infarction reveals early markers of myocardial injuryJournal of Clinical Investigation, 2008
- Purine Metabolism in Heart Failure: Oxidant Biology and Therapeutic IndicationsCongestive Heart Failure, 2008
- Differences in postmortem urea nitrogen, creatinine and uric acid levels between blood and pericardial fluid in acute deathLegal Medicine, 2007
- Inhibition of xanthine oxidase improves myocardial contractility in patients with ischemic cardiomyopathyFree Radical Biology and Medicine, 2006
- Pathophysiology of Coronary Artery DiseaseCirculation, 2005
- Observation and identification of metabolites emerging during postmortem decomposition of brain tissue by means of in situ1H‐magnetic resonance spectroscopyMagnetic Resonance in Medicine, 2002
- The Physiology of Endothelial Xanthine Oxidase: From Urate Catabolism to Reperfusion Injury to Inflammatory Signal TransductionMicrocirculation, 2002
- Sudden coronary death. A postmortem study in 208 selected cases compared to 97 “control” subjectsAmerican Heart Journal, 1979